{"id":8242,"date":"2012-02-15T13:13:53","date_gmt":"2012-02-15T18:13:53","guid":{"rendered":"http:\/\/sciencebusiness.technewslit.com\/?p=8242"},"modified":"2012-02-15T13:13:53","modified_gmt":"2012-02-15T18:13:53","slug":"u-s-patent-issued-for-stem-cell-wound-care-technology","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=8242","title":{"rendered":"U.S. Patent Issued for Stem Cell Wound Care Technology"},"content":{"rendered":"<figure id=\"attachment_1176\" aria-describedby=\"caption-attachment-1176\" style=\"width: 200px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/09\/StemCells_NSF.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-1176\" title=\"StemCells_NSF\" src=\"http:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/09\/StemCells_NSF.jpg\" alt=\"Stem Cells (NSF)\" width=\"200\" height=\"200\" srcset=\"https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/09\/StemCells_NSF.jpg 200w, https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/09\/StemCells_NSF-150x150.jpg 150w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><\/a><figcaption id=\"caption-attachment-1176\" class=\"wp-caption-text\">Stem Cells (National Science Foundation)<\/figcaption><\/figure>\n<p><a href=\"http:\/\/www.stemedica.com\/info\/allogeneic-adult-stem-cells\/wound-care-cellular-scaffold\/2012-0214-Stemedica-Granted-Patent-Cellular-Scaffold.asp\">Stemedica Cell Technologies Inc.<\/a> in San Diego has been granted a patent for its scaffolding technology based on adult stem cells used in healing wounds. Patent <a href=\"http:\/\/patft.uspto.gov\/netacgi\/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=8,105,380.PN.&amp;OS=PN\/8,105,380&amp;RS=PN\/8,105,380\">number 8,105,380<\/a> was awarded to Ludmilla and Alex Kharazi, Stemedica&#8217;s senior scientist and chief technology officer respectively, by the United States Patent and Trademark Office on 31 January 2012.<\/p>\n<p>The patent covers Stemedica&#8217;s process for building a scaffold seeded with mesenchymal stem cells &#8212; those that transform into multiple cell types &#8212; and ectodermal or outer skin cells in a sandwich-like array. The scaffold provides a form for regenerating tissue, particularly for healing severely damaged tissue found in burns and wounds.<\/p>\n<p>The company&#8217;s technology includes a biodegradable layer that enhances tissue growth and delivery of cytokines &#8212; proteins that encourage cell signaling and respond to infections &#8212; and a non-absorbable biological bandage layer that encourages closure of the broken skin. The scaffold is designed to mimic human skin and suitable for transplantation.<\/p>\n<p>Stemedica is a licensed manufacturer of adult stem cells for pre-clinical research and clinical trials. The company is involved in a phase 1-2 clinical study of bone marrow stem cells to treat ischemic stroke, where blood to the brain is blocked. Stemedica is also conducting pre-clinical research in the use of neural stem cells to treat spinal cord injuries.<\/p>\n<p>Read more: <a href=\"http:\/\/sciencebusiness.technewslit.com\/?p=7539\" rel=\"prev\">Patent Awarded for Stem Cell Generation Process<\/a><\/p>\n<p style=\"text-align: center;\">*\u00a0\u00a0\u00a0\u00a0 *\u00a0\u00a0\u00a0\u00a0 *<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Stemedica Cell Technologies Inc. in San Diego has been granted a patent for its scaffolding technology based on adult stem cells used in healing wounds. Patent number 8,105,380 was awarded to Ludmilla and Alex Kharazi, Stemedica&#8217;s senior scientist and chief technology officer respectively, by the United States Patent and Trademark Office on 31 January 2012. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[31,28,86,64,77,29,48,7],"class_list":["post-8242","post","type-post","status-publish","format-standard","hentry","category-i-p","tag-biomedical","tag-clinical-trials","tag-engineering","tag-life-sciences","tag-medical-device","tag-patent","tag-stem-cells","tag-uspto"],"_links":{"self":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/8242","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8242"}],"version-history":[{"count":3,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/8242\/revisions"}],"predecessor-version":[{"id":8245,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/8242\/revisions\/8245"}],"wp:attachment":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8242"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8242"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8242"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}